Dietary support with Boswellia resin in canine inflammatory joint and spinal disease (2004, Schweiz Arch Tierheilkd)
-
Benefits claimed: Boswellia resin extract (400 mg/10 kg body weight daily for 6 weeks) provided symptomatic relief in 71% of dogs after two weeks, with statistically significant reductions in intermittent lameness, local pain, stiff gait, and aggravation from movement or rest after six weeks. It supports anti-rheumatic and anti-inflammatory effects, improving mobility and quality of life in dogs with chronic osteoarthritis and degenerative spinal/joint conditions.
Effects of a nutritional supplement in dogs affected by osteoarthritis (2019, Veterinary Medicine and Science)
-
Benefits claimed: As part of a supplement including boswellia, it significantly improved clinical signs such as lameness, pain on manipulation/palpation, range of motion, and joint swelling over 90 days, with reduced oxidative stress and inflammation (e.g., lower cholesterol and inflammatory markers). Boswellia specifically inhibits leukotriene synthesis, contributing to anti-inflammatory effects that alleviate arthritis symptoms, enhance metabolic health, and support overall joint function without adverse effects.
Preliminary results on the efficacy of a dietary supplement combined with physiotherapy in dogs with osteoarthritis on biomarkers of oxidative stress and inflammation (2021, Italian Journal of Animal Science)
-
Link: https://www.tandfonline.com/doi/full/10.1080/1828051X.2021.2004249
-
Benefits claimed: In a supplement containing boswellia combined with physiotherapy, it led to significant reductions in serum C-reactive protein (a key inflammation marker) and supported antioxidant activity (e.g., changes in glutathione levels). It offers anti-inflammatory properties for treating OA and related disorders, potentially reducing pain and improving metabolic parameters, though pain score differences were not statistically significant between groups.